Karyopharm Therapeutics
KPTI
KPTI
115 hedge funds and large institutions have $482M invested in Karyopharm Therapeutics in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
35% less capital invested
Capital invested by funds: $738M → $482M (-$256M)
38% less call options, than puts
Call options by funds: $553K | Put options by funds: $894K
Holders
115
Holding in Top 10
1
Calls
$553K
Puts
$894K
Top Buyers
| 1 | +$7.14M | |
| 2 | +$6.8M | |
| 3 | +$6.62M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.48M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.97M |
Top Sellers
| 1 | -$6.41M | |
| 2 | -$3.64M | |
| 3 | -$2.77M | |
| 4 |
DAM
Doheny Asset Management
Los Angeles,
California
|
-$1.58M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.38M |